Cargando…

Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data

BACKGROUND: The continual reassessment method (CRM) requires an underlying model of the dose-toxicity relationship (“prior skeleton”) and there is limited guidance of what this should be when little is known about this association. In this manuscript the impact of applying the CRM with different pri...

Descripción completa

Detalles Bibliográficos
Autores principales:	James, Gareth D., Symeonides, Stefan N., Marshall, Jayne, Young, Julia, Clack, Glen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007718/ https://www.ncbi.nlm.nih.gov/pubmed/27581751 http://dx.doi.org/10.1186/s12885-016-2702-6

Ejemplares similares

Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies
por: James, G. D., et al.
Publicado: (2021)

Dose Finding by the Continual Reassessment Method
por: Cheung, Ying
Publicado: (2011)

A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method
por: North, Bernard, et al.
Publicado: (2019)

A Comprehensive Comparison of the Continual Reassessment Method to the Standard 3 + 3 Dose Escalation Scheme in Phase I Dose-Finding Studies
por: Iasonos, Alexia, et al.
Publicado: (2008)

Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo
por: Lai, Mengzhen, et al.
Publicado: (2023)

Importance of the postcranial skeleton in eusuchian phylogeny: Reassessing the systematics of allodaposuchid crocodylians
por: Blanco, Alejandro
Publicado: (2021)

De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
por: Thomas, Pepijn W. A., et al.
Publicado: (2022)

How to design a dose-finding study using the continual reassessment method
por: Wheeler, Graham M., et al.
Publicado: (2019)

Local continual reassessment methods for dose finding and optimization in drug-combination trials
por: Zhang, Jingyi, et al.
Publicado: (2023)

A nonparametric Bayesian continual reassessment method in single-agent dose-finding studies
por: Tang, Niansheng, et al.
Publicado: (2018)

Extending the Continual Reassessment Method to accommodate step‐up dosing in Phase I trials
por: Braun, Thomas M., et al.
Publicado: (2022)

Phase I dose-escalation oncology trials with sequential multiple schedules
por: Günhan, Burak Kürsad, et al.
Publicado: (2021)

Reassessment of the lung dose limits for radioembolization
por: Kappadath, S. Cheenu, et al.
Publicado: (2021)

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)
por: Keizer, Ron J., et al.
Publicado: (2011)

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer
por: Kolinsky, M.P., et al.
Publicado: (2020)

Reassessing the risk from rabies: A continuing threat to the UK?
por: Banyard, Ashley C., et al.
Publicado: (2010)

A placebo-controlled Bayesian dose finding design based on continuous reassessment method with application to stroke research
por: Cai, Chunyan, et al.
Publicado: (2017)

Increases in Entamoeba histolytica Antibody–Positive Rates in Human Immunodeficiency Virus–Infected and Noninfected Patients in Japan: A 10-Year Hospital-Based Study of 3,514 Patients
por: Yanagawa, Yasuaki, et al.
Publicado: (2016)

A Reassessment of the SIDS Back to Sleep Campaign
por: Pelligra, Ralph, et al.
Publicado: (2005)

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
por: Sands, Bruce E., et al.
Publicado: (2019)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

The life cycle of chondrocytes in the developing skeleton
por: Shum, Lillian, et al.
Publicado: (2002)

Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial
por: Mozgunov, Pavel, et al.
Publicado: (2022)

Phase I dose escalation trial of stereotactic radiotherapy prior to robotic prostatectomy in high risk prostate cancer
por: Liveringhouse, Casey, et al.
Publicado: (2021)

A novel model of the continual reassessment method in Phase I trial
por: Zhang, Weijia, et al.
Publicado: (2023)

Thrombosis with thrombocytopenia after second dose of AZD-1222
Publicado: (2021)

Mulder DT, Mahé ER, Dowar M, et al. CapTCR-seq: hybrid capture for T-cell receptor repertoire profiling. Blood Adv. 2018;2(23):3506-3514.
Publicado: (2019)

Improving safety of the continual reassessment method via a modified allocation rule
por: Mozgunov, Pavel, et al.
Publicado: (2019)

Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models
por: Pantoja, Kristyn, et al.
Publicado: (2022)

Dose escalation of a curcuminoid formulation
por: Lao, Christopher D, et al.
Publicado: (2006)

Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
por: Coombes, R. C., et al.
Publicado: (2023)

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma
por: Thomas, Anne, et al.
Publicado: (2020)

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
por: Wheeler, Graham M.
Publicado: (2016)

Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy
por: Garrett, C R, et al.
Publicado: (2011)

The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Model Selection Approach
por: Pan, Haitao, et al.
Publicado: (2014)

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock
por: Morris, Peter E, et al.
Publicado: (2012)

The Skeleton
Publicado: (1864)

Determination of the ED95 of intrathecal hyperbaric prilocaine with sufentanil for scheduled cesarean delivery: a dose-finding study based on the continual reassessment method
por: Goffard, P., et al.
Publicado: (2020)

Radiation treatment planning with embedded dose escalation
por: Hrinivich, William T., et al.
Publicado: (2019)

The role of biological dose-escalation for pancreatic cancer
por: Bruynzeel, Anna M.E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c0t1j11gon7v7h6hut8n1ioh8h